Culbertson A N & Co. Inc. Increases Stock Position in The Clorox Company (NYSE:CLX)

Culbertson A N & Co. Inc. increased its stake in shares of The Clorox Company (NYSE:CLX) by 52.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,362 shares of the company’s stock after purchasing an additional 4,919 shares during the period. Culbertson A N & Co. Inc.’s holdings in Clorox were worth $2,333,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mizuho Securities USA LLC raised its stake in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares during the last quarter. Ilex Capital Partners UK LLP lifted its holdings in Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after acquiring an additional 453,624 shares during the period. International Assets Investment Management LLC boosted its position in Clorox by 424.9% in the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after purchasing an additional 435,971 shares during the last quarter. Boston Trust Walden Corp grew its stake in shares of Clorox by 5,442.5% during the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after purchasing an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in shares of Clorox by 302.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after purchasing an additional 265,455 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on CLX. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Barclays cut their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday. DA Davidson raised their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. JPMorgan Chase & Co. boosted their price target on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a report on Thursday, January 16th. Finally, Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and raised their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $156.54.

Clorox Trading Down 0.1 %

Clorox stock opened at $160.31 on Tuesday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The firm’s 50 day moving average price is $164.25 and its 200-day moving average price is $156.71. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market cap of $19.84 billion, a P/E ratio of 55.86, a PEG ratio of 2.90 and a beta of 0.42.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.49 EPS. On average, equities analysts predict that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.03%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.